Cargando…

The prognostic value of thyroid-stimulating immunoglobulin in the management of Graves’ disease

BACKGROUND: The bioassay of thyroid-stimulating immunoglobulin was reported to have a similar performance to the commonly used thyroid-stimulating hormone binding inhibition assay, also known as thyroid receptor antibody assay. The normal reference range of thyroid receptor antibody levels indicates...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Yulin, Zhou, Mengxi, Qi, Yicheng, Wang, Weiqing, Chen, Xinxin, Wang, Shu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481717/ https://www.ncbi.nlm.nih.gov/pubmed/34603682 http://dx.doi.org/10.1177/20420188211044943

Ejemplares similares

Expansion of inflammatory monocytes in periphery and infiltrated into thyroid tissue in Graves’ disease
por: Chen, Xinxin, et al.
Publicado: (2021)

Serum and thyroid tissue level of let-7b and their correlation with TRAb in Graves’ disease
por: Chen, Xinxin, et al.
Publicado: (2018)

Down-regulated resistin level in consequence of decreased neutrophil counts in untreated Grave's disease
por: Peng, Ying, et al.
Publicado: (2016)

MicroRNA-4443 Causes CD4+ T Cells Dysfunction by Targeting TNFR-Associated Factor 4 in Graves’ Disease
por: Qi, Yicheng, et al.
Publicado: (2017)

Role of Maternal Thyroid-Stimulating Immunoglobulin in Graves' Disease for Predicting Perinatal Thyroid Dysfunction
por: Cui, Yiwen, et al.
Publicado: (2019)

Evaluation of the diagnostic performance of thyroid‐stimulating immunoglobulin and thyrotropin receptor antibodies for Graves' disease
por: Xu, Shiji, et al.
Publicado: (2023)

Comparison Between Thyroid Stimulating Immunoglobulin and TSH-Receptor Antibodies in the Management of Graves’ Orbitopathy
por: Khamisi, Selwan, et al.
Publicado: (2023)

SAT-415 Clinical Performance of Thyroid-Stimulating Immunoglobulin for Graves′ Disease Diagnosis
por: Marui, Suemi, et al.
Publicado: (2020)

The Prediction Model Using Thyroid-stimulating Immunoglobulin Bioassay For Relapse of Graves’ Disease
por: Baek, Han-Sang, et al.
Publicado: (2022)

Usefulness of Functional Thyroid-Stimulating and Thyroid-Blocking Immunoglobulin Bioassays in an Atypical Presentation of Graves’ Disease
por: Sherfan, Julie, et al.
Publicado: (2023)

Association of clinical course with thyroid-stimulating immunoglobulin in Graves’ ophthalmopathy in Mongolians
por: Bayarmunkh, Oyungerel, et al.
Publicado: (2022)

Elevated Graves’ Disease-Specific Thyroid-Stimulating Immunoglobulin and Thyroid Stimulating Hormone Receptor Antibody in a Patient With Subacute Thyroiditis
por: Alvin Mathew, Anu, et al.
Publicado: (2021)

Diagnostic Values of Free Triiodothyronine and Free Thyroxine and the Ratio of Free Triiodothyronine to Free Thyroxine in Thyrotoxicosis
por: Chen, Xinxin, et al.
Publicado: (2018)

SAT-422 Evaluation of the Siemens Thyroid Stimulating Immunoglobulin (TSI) Assay for Diagnosis and Prognosis of Graves’ Disease
por: Paul, Heather, et al.
Publicado: (2020)

Decreased SIRT1 expression in the peripheral blood of patients with Graves’ disease
por: Yin, Qinglei, et al.
Publicado: (2020)

Genetic associations of the thyroid stimulating hormone receptor gene with Graves diseases and Graves ophthalmopathy: A meta-analysis
por: Xiong, Haibo, et al.
Publicado: (2016)

The Early Changes in Thyroid-Stimulating Immunoglobulin Bioassay over Anti-Thyroid Drug Treatment Could Predict Prognosis of Graves’ Disease
por: Yu, Jin, et al.
Publicado: (2023)

Antibodies against thyroid-stimulating hormone receptor cause maternal-neonatal transmission of Graves' Disease
por: Yu, Yue, et al.
Publicado: (2021)

Agoitrous Graves’ Hyperthyroidism with Markedly Elevated Thyroid Stimulating Immunoglobulin Titre displaying Rapid Response to Carbimazole with Discordant Thyroid Function
por: Kon, Yin Chian, et al.
Publicado: (2020)

Methotrexate plus reduced or full-dose glucocorticoids for the treatment of active, moderate-to-severe Graves’ orbitopathy
por: Shen, Liyun, et al.
Publicado: (2022)

Management of Graves Thyroidal and Extrathyroidal Disease: An Update
por: Kahaly, George J
Publicado: (2020)

Prognostic significance of thyroid-stimulating hormone receptor antibodies in moderate-to-severe graves’ orbitopathy
por: Park, Jungyul, et al.
Publicado: (2023)

Effects of glucocorticoid pulse therapy on thyroid function and thyroid antibodies in children with graves’ disease
por: Hu, Yanyan, et al.
Publicado: (2021)

MON-593 Thyrotropin Receptor Stimulating Immunoglobulin: Clinical Utility in Graves' Disease Diagnosis
por: Marques, Bernardo, et al.
Publicado: (2019)

Clinical Significance of Thyrotrophin Binding Inhibitor Immunoglobulins in Patients with Graves’ Disease and Various Types of Thyroiditis
por: Lee, Chong Suk, et al.
Publicado: (1987)

Serum Ratio of Free Triiodothyronine to Thyroid-Stimulating Hormone: A Novel Index for Distinguishing Graves’ Disease From Autoimmune Thyroiditis
por: Wu, Zhiyong, et al.
Publicado: (2021)

Thyroid Drugging in Graves' Disease
por: Chaudhuri, R. N.
Publicado: (1941)

The Correlations of Graves' Disease and Thyroiditis
por: Eason, John
Publicado: (1928)

The genetic landscape of benign thyroid nodules revealed by whole exome and transcriptome sequencing
por: Ye, Lei, et al.
Publicado: (2017)

The Prognostic Value of Thyroid-Stimulating Hormone in Patients with Coronary Artery Disease and Depression
por: Li, Weiya, et al.
Publicado: (2022)

Corrigendum: The genetic landscape of benign thyroid nodules revealed by whole exome and transcriptome sequencing
por: Ye, Lei, et al.
Publicado: (2017)

The value of FT4/TSH ratio in the differential diagnosis of Graves’ disease and subacute thyroiditis
por: Zhang, Yingjie, et al.
Publicado: (2023)

Effect of the pregnant mice with Graves’ disease on thyroid function in the offspring
por: Liu, Qianqi, et al.
Publicado: (2013)

Persistent Graves’ hyperthyroidism despite rapid negative conversion of thyroid-stimulating hormone-binding inhibitory immunoglobulin assay results: a case report
por: Ohara, Nobumasa, et al.
Publicado: (2017)

High levels of thyroid hormones promote recurrence of Graves' disease via overexpression of B‐cell‐activating factor
por: Liu, Shu, et al.
Publicado: (2022)

2022 European Thyroid Association Guideline for the management of pediatric Graves’ disease
por: Mooij, Christiaan F, et al.
Publicado: (2021)

Prognostic Value of (99m)Tc-Pertechnetate Thyroid Scintigraphy in Radioiodine Therapy in a Cohort of Chinese Graves' Disease Patients: A Pilot Clinical Study
por: Hou, Haifeng, et al.
Publicado: (2015)

Longitudinal association of thyroid-stimulating immunoglobulin levels with clinical characteristics in thyroid eye disease
por: Ko, JaeSang, et al.
Publicado: (2022)

Cut off value of technetium uptake in the differential diagnosis of Graves(,) disease and subacute thyroiditis
por: Fadime, Demir
Publicado: (2020)

lncRNA:mRNA expression profile in CD4+ T cells from patients with Graves’ disease
por: Yin, Qinglei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_v4sgu48b234sc6v24dltftd8ji